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Abstract
Background: Whole genome studies have highlighted duplicated genes as important substrates for adaptive evolution. We
have investigated adaptive evolution in this class of genes in the human parasite Trypanosoma brucei, as indicated by the
ratio of non-synonymous (amino-acid changing) to synonymous (amino acid retaining) nucleotide substitution rates.
Methodology/Principal Findings: We have identified duplicated genes that are most rapidly evolving in this important
human parasite. This is the first attempt to investigate adaptive evolution in this species at the codon level. We identify 109
genes within 23 clusters of paralogous gene expansions to be subject to positive selection.
Conclusions/Significance: Genes identified include surface antigens in both the mammalian and insect host life cycle stage
suggesting that competitive interaction is not solely with the adaptive immune system of the mammalian host. Also surface
transporters related to drug resistance and genes related to developmental progression are detected. We discuss how
adaptive evolution of these genes may highlight lineage specific processes essential for parasite survival. We also discuss
the implications of adaptive evolution of these targets for parasite biology and control.
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Introduction
Sub species of the parasite, Trypanosoma brucei from the family
trypanasomatidae are the causative agent of Nagana in livestock and
human sleeping sickness. No vaccines exist for this disease and
current control regimes face problems of emerging drug resistance
and toxicity [1]. This economic and medical importance of
Trypanosoma species promoted whole genome sequencing of T. brucei
and continued efforts to interpret the genome of this organism [2].
Through this genome project it was hoped that the accumulation
and interpretation of data would provide an opportunity to better
understand trypanosome biology, and hence improve disease control
by identification of potential new drug targets, and by greater
understanding of resistance to current drug control strategies. Whole
genome data can facilitate investigation of a particular trait or disease
if candidate genes are known a priori, or they can be utilised to search
globally for extraordinary evolution and adaptation of genes which
may reveal novel insights to species-specific biology.
To this end, we have inferred natural selection by estimation of v,
the ratio of non-synonymous (dN, amino acid changing) to
synonymous (dS, amino acid retaining) substitution rates (v= dN/
dS). With v,0, v=1 and v.1 representing purifying, neutral and
adaptive evolution, respectively [3]. Identification of genes whose v
ratio is greater than 1 is thus persuasive evidence for adaptive
evolution of the gene [4]. The validity of this type of approach has
been verified both by computer simulations [5,6] and by a growing
number of cases, including recent reports of experimental verifica-
tion of statistical predictions (for review see [7]).
Previous analysis of the T. brucei genome together with related
trypanasomatidae (T. cruzi and Leishmania major) identified families of
orthologous genes shared between these species and gene families
which are specific to the T. brucei lineage [8]. Sadly, the estimated
long divergence time (200–500 MY) [9,10] between these three
species precludes the confident interpretation of methods to model
adaptive evolution across the tri-genome orthologous gene sets.
However, using pairwise comparisons of genes within these groups
we can show that for the majority of orthologous genes v is small,
confirming the general assumption that non-synonymous mutations
are selected against and that purifying selection is the dominant force
in evolution. In contrast, paralogous gene expansions in T. brucei
exhibit a relaxation of selection and are more likely to be subject to
positive selection (Figure 1). Thus we have focused our studies on the
adaptive evolution of the duplicated paralogous gene families in the
single parasite T. brucei.
We identify lineage specific genes evolving by duplication and
adaptive evolution which are surface proteins expressed in both
the insect vector and mammalian hosts, and proteins essential for
development, and survival of the parasite.
Results
Comparison of pairwise estimates of selection
The clusters of homologous T. brucei, T. cruzi and L. major genes
identified previously [8] were separated into four groups; clusters
of orthologous genes (COGs) of 1:1:1 orthologous trios without
duplication in any lineage (1174 clusters); COGs of 1:1 T. brucei:T.
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cruzi gene pairs (67 clusters); 1:1 T. brucei:L. major gene pairs (78
clusters) or T. brucei clusters of paralogous genes (CPGs, 90
clusters). Within each cluster every gene was compared in a
pairwise manner and ‘‘gene-wide’’ estimates of dN/dS were
determined. A median value for each cluster was calculated.
Where estimates from codeml are at the upper bound (999 for dN/
dS) the values were recorded as infinity and were not included in
median calculations.
A cumulative percentage frequency plot of the median cluster
dN/dS shows that for the majority of genes, comparisons between
species typically exhibit strong purifying selection (Figure 1).
Conversely the T. brucei CPG distribution shows a definite shift to
the right representing a relaxation of purifying selection and a
higher percentage of genes with dN/dS.1 (Figure 1). As lineage
specific duplicates are often found to be the subject to adaptive
evolution [11–13] these genes offer and exciting insight into the
specific biology of T. brucei and were investigated further.
Duplicated genes subject to positive selection
Of the 90 T. brucei CPGs, 40 contained three or more genes
and could be investigated for adaptive evolution using codon
models (see methods). Using this approach 23 CPGs containing a
total of 109 genes showed robust evidence of adaptive evolution
at p,0.05 in both M2 and M8 tests (1 cluster with p,0.05, 3
clusters with p,0.01 and 28 with p,0.001 in both M1–M2 and
M7–M8 tests, Table 1). The Benjamini-Hochberg method [14]
for controlling the false discovery rate in multiple comparisons
was implemented at the a=0.05 level. A single significant gene
cluster (procyclin precursor) was non-significant following this
method of correction. However using an additional stringent test
of selection (M8a) all 23 CPGs including the procyclin CPG
showed significant evidence of positive selection at p,0.05
following Benjamini-Hochberg correction, thus we consider
these 23 CPGs to have significant evidence of positive selection.
Parameter estimates for each positively selected cluster are
shown in Supplementary Table S1. The high proportion of
CPGs with evidence of positive selection (23/40, 57.5%)
supports the assumptions that paralogous gene expansions often
form the substrate for adaptive change. Additionally, it is evident
that multiple clusters of related genes were identified as being
subject to adaptive evolution, highlighting both the extensive
gene duplication within these families consistent with previous
studies [15] and the impact of adaptive evolution within
particular gene types (Table 1).
Functional annotation of positively selected genes
Annotation of the predicted cellular location of encoded proteins
suggests that genes at the surface or secreted from the parasite are
more often subject to adaptive evolution, (Table 2). Further
investigation of all genes highlights that whilst compared to the
COGs those genes found within CPGs are more often predicted to
be surface-located either through possession of transmembrane or
GPI anchored regions (Figure 2). However, only the secreted
category is significantly over abundant (p=0.044 by binomial test).
Analysis of Pfam domains and gene ontology (GO) terms
showed that the positively selected genes represent a small
functional group of proteins, with only five Pfam domain types
and associated GO terms detected. Although few in number, the
domains detected are often specific or enriched in the CPGs
compared to COGs and often in positively selected genes, for
example 33 Guanylate cyclase domain containing proteins are
detected from the 300 CPGs and 26 of these 33 are encoded by
genes subject to positive selection, whilst only 14 Guanylate cyclase
domains are found amongst the 4896 COG proteins. Additionally
the Pfam domain Nucleoside_tran associated with nucleotide
transport is only present in genes in CPGs and that all six proteins
with this domain are under positive selection.
Adaptive evolution of 65 KDa and 75 KDa invariant
surface glycoproteins
Like the widely known variable surface glycoprotein (VSG)
genes involved in parasite survival by antigen switching [16], the
invariant surface glycoproteins (ISG65, ISG75) are also found at
high density on the surface of the blood-stage form of the parasite
[17]. The two forms of invariant proteins are distinguishable by
mass although a single round of a PSI-BLAST search [18]
identifies them as potential homologues (E value 3 610210).
Additionally, the conserved protein architecture of a large
extracellular domain linked to a short intracellular domain by a
single transmembrane domain betrays the likely common ancestry
of both glycoprotein families.
Two clusters of ISG65 and a single cluster of ISG75 genes were
identified to be evolving under positive selection. Of the ISG65
genes for the cluster 21719250 one codon was predicted to have
dN/dS.1 and three codons for cluster 19416372 by both M2 and
M8 models. In contrast 16 codons were predicted by M2 and M8
in the ISG75 cluster 20195704 (see table S1 for details of sites).
Although none of the positions identified in either ISG65 or
ISG75 are orthologous, all are located in the extracellular region.
Adaptive evolution of adenosine transporters
The CPG 20117965 encodes the P1 form of the nucleoside
transporter a predicted eleven transmembrane transporter protein.
The four sites with significant evidence of dN/dS.1 in both the M2
and M8 models are located in the extracellular (EC) loops of this
protein, one S55 in EC1 and three S333, M334 and F339 in EC4.
The adenosine transporter 2 gene is part of the nucleoside
transporter family and is of particular interest as loss of function of
the paralogous TbAT1 gene which encodes the P2 type of
nucleoside transporter is related to drug resistance in T. brucei brucei
[19,20]. However, sites with significant evidence of dN/dS.1 are
not homologous to those mutations (L71V, A178T, G181E,
D239G, N276S) seen in drug resistant isolates [21].
Adaptive evolution of amino acid transporters
Two clusters of homologous amino acid transporter genes were
identified as having evolved under positive selection, CPGs
19796418 and 22063411. These CPGs exhibited six and nine
Figure 1. dN/dS values for CPG and COG genes. Cumulative
frequency plot of dN/dS values for duplicated paralogous T. brucei CPGs
in comparison to T. brucei-T. cruzi and T. brucei-L. major COGs. The T.
brucei CPGs exhibit a relaxed purifying selection and are more likely to
be subject to positive adaptive evolution.
doi:10.1371/journal.pone.0002295.g001
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codons with significant evidence of adaptive evolution respectively.
Recent analysis of the amino acid transporter genes in kinetoplas-
tid species grouped these two clusters as a single T. brucei specific
locus containing six genes (named AAT4Tb) which have
potentially evolved by tandem duplication and which exhibit
evidence of elevated evolutionary rate [22]. Here we show that
each of the two clades of the AAT4Tb cluster exhibits evidence of
positive selection. However, the sites detected are not orthologous
between the two CPGs.
Adaptive evolution of procyclin
A single cluster (CPG 19416463) of five procyclin genes
exhibited positive selection, only a single site, G51 was predicted
with dN/dS.1. The function of site G51 is unknown, but is N-
terminal to the Glu-Pro repeat region. The number of Glu-Pro
repeats and similarity searches places this procyclin in the EP3
procyclin family [23].
Adaptive evolution of receptor-type adenylate cyclase
genes
Four CPGs of receptor-type adenylate cyclase genes (ACs) were
identified, containing a total of 29 genes. Like membrane bound
cyclases of metazoans, trypanosome ACs are single transmembrane
spanning proteins with an intracellular cyclase domain which has
been crystallised (PDB 1FX2/1FX4 [24,25]) to which each cluster
was aligned.
Predicted positively selected sites were largely located within the
extracellular part of the protein, with only four codons predicted to be
subject to positive selection in the intracellular cyclase domain
(Figure 3). Previously the extracellular domain has been thought to
have no similarity to other proteins or protein domains but is predicted
to have a ligand binding role [26]. However a psi-blast search of the nr
database with the n-terminal portion of a representative AC protein
(Tb927.6.760) as a query identified a probable leucine/isoleucine/
valine-binding protein precursor from the bacteria Bradyrhizobium
japonicum (NP_773188.1 Psi-blast round 2 Evalue=8610210) as a
candidate homologue of the kinetoplastid AC family. To confirm this
prediction, a hidden Markov model (HMM) of the n-terminal region
of ACs was used to search HMMs generated from all PDB files (PDB
version 70, April 2007) using HHpred a method of hidden Markov
model comparison tool utilising secondary structure information to
identify distant homologues with high sensitivity [27]. Using the local
alignment mode, Tb927.6.760 aligned to E. coli L-leucine-binding
protein (PDB 2LBP [28]) with a probability of 99.7 (Evalue
1.6610214).
Table 1. Summary of sites tests for positive selection.
Description CPGa N LRT statistics Parameter estimates
M1 vs. M2 M7 vs. M8 M8 vs. M8a
% of sites with
dN/dS.1 dN/dS
M2 M8
65 kDa ISG 19416372 3 13.77** 14.58*** 13.77*** 8 8 4.34
65 kDa ISG 21719250 5 45.50*** 45.56*** 45.49*** 12 12 12.68
75 kDa ISG 20195704 3 40.73*** 41.14*** 40.73*** 18 18 3.96
Adenosine transporter 20117965 6 24.49*** 29.03*** 22.74*** 1 1 9.56
Amino acid transporter 22063411 3 23.20*** 23.24*** 23.20*** 11 11 8.14
Amino acid transporter 19796418 3 30.47*** 30.52*** 30.51*** 3 3 27.7
Procyclin 19416463 5 6.11* 8.18* 6.10* 1 1 8.24
GRESAG2 20975481 3 18.36*** 18.51*** 18.36*** 5 5 17.69
Hypothetical 20115952 3 10.89** 10.87** 10.24** 11 15 10.07
Hypothetical 19340333 4 13.43** 13.43** 13.43*** 6 6 10.72
Hypothetical 20206217 4 13.49** 13.51** 13.49*** 4 4 23.94
Hypothetical 21586974 9 16.62*** 16.63*** 16.08*** 14 14 5.86
Hypothetical 21769349 3 16.18*** 16.49*** 16.18*** 9 9 10.6
Receptor-type AC 19651441 5 46.95*** 47.02*** 46.95*** 9 9 7.21
Receptor-type AC 20115358 8 131.60*** 131.41*** 131.09*** 7 7 4.6
Receptor-type AC 21943524 8 183.29*** 182.30*** 179.44*** 6 5 6.06
Receptor-type AC 21139502 5 279.88*** 279.75*** 279.74*** 10 10 12.95
RHS 20343633 6 17.58*** 17.89*** 17.56*** 22 25 2.33
RHS 20439293 3 32.94*** 33.07*** 32.94*** 9 9 12.26
RHS 20461581 5 38.14*** 38.36*** 38.09*** 3 3 35.12
RHS 19651414 8 102.43*** 102.55*** 102.43*** 18 18 6.87
RHS 21995461 3 106.01*** 106.08*** 105.98*** 4 4 33.46
RHS 20529562 4 157.08*** 157.19*** 156.87*** 7 7 10.12
N, number of species analysed; M1 vs. M2, likelihood ratio test statistic for model M1 versus M2; M7 vs. M8, likelihood ratio test statistic for model M7 versus M8;
Parameter estimates: percentage of sites in dN/dS.1 category and estimated dN/dS parameter under model M8. ISG, invariant surface glycoprotein. RHS
retrotransposon hot spot protein. * Significance with P,0.05; ** Significance with P,0.01; *** Significance with P,0.001. A CPG jaccard cluster number from El Sayed et
al [8].
doi:10.1371/journal.pone.0002295.t001
Positive Selection in T.brucei
PLoS ONE | www.plosone.org 3 May 2008 | Volume 3 | Issue 5 | e2295
Discussion
Parasite genome sequencing projects provide an invaluable
resource for biologists; however the successful mining of any large
scale data set is key to new avenues of research. Thus a greater
understanding of adaptive evolution within parasitic species will
link genome studies to the biology of parasites and identify
potential new targets for intervention. Here we have used the data
from the genomes of human pathogens to scan for genes subject to
adaptive molecular evolution and highlight the areas of the protein
coding genome which have been extensively modified by natural
selection. The genes identified are frequently duplicated, often
independently in T. brucei and the majority of the expanded
adaptive proteins are surface expressed, suggesting interaction
with the external host environment.
Genes identified include adenosine transporters related to the
P2 type associated with drug resistance [19,20] and molecules
involved in life cycle progression; the procyclins expressed in late
procyclic parasites in the insect host [29], and Adenylate cyclises
(ACs) which form part of the signal transduction pathway
generating cAMP. ACs are the subject of particular interest as
cAMP is thought to influence the life-cycle progression of T. brucei
[24], and understanding of ACs may provide insight into the
mechanism of parasite development and transmission. The
extensive duplication and diversification of the ACs suggest that
these genes may be part of an essential sensory system and
exemplify the complexity of the control of parasite lifecycle
progression. The migration and development in different hosts
requires tight coupling of environmental sensing, gene expression
and parasite development. The variation of the extracellular LBP
homologous region of ACs could therefore be to detect multiple
ligands by variation of binding specificity or association/
dissociation dynamics of ligand interaction thus allowing a range
of stimuli to potentiate a signal via the ACs. For example, in T.
Table 2. Functional annotation of CPGs subject to positive selection.
Description CPGs
Predicted
Location Size a Pfam Domains Biological Process Molecular Function
65 kDa ISG 19416372, 21719250 Su 434–436 n/d n/d n/d
75 kDa ISG 20195704 Su 522–523 n/d n/d n/d




Amino acid transporter 19796418, 22063411 Su 450–490 Aa_trans,
Trp_Tyr_perm
amino acid transport amine transmembrane
transporter activity
EP1 procyclin 19416463 Su 123–141 n/d n/d n/d
GRESAG2 20975481 Su 454–457 n/d n/d n/d
Receptor-type AC 19651441, 20115358,
21139502, 21943524









Se, Su, In 557–860 n/d n/d n/d
Predicted cellular location based on GPI signal peptide and transmembrane domain prediction for each member of each cluster (see methods) Su; surface, Se; secreted,
In; Intracellular. Pfam domains were detected using HMMER [47] to search the Pfam database [54]. Gene Ontology terms were linked to predicted Pfam domains using
Pfam2GO (http://www.geneontology.org/). For details of gene annotation and prediction of location see methods.
doi:10.1371/journal.pone.0002295.t002
Figure 2. Histogram of predicted location of COG and CPG genes. Protein products were tested for transmembrane (TM) domains, secretory
signal sequences and glycosylphosphatidylinositol (GPI) anchor sequences. Secreted; secretory signal sequence positive TM and GPI-anchor negative,
surface; TM or GPI-anchor positive, Intracellular; secretory signal, TM and GPI-anchor negative. COGs, all 1:1:1 T. brucei:T. cruzi:L. major clusters if
orthologous genes. All CPG, all T. brucei CPGs. CPGs.2 members, all CPGs tested for positive selection using codon model. dN/dS.1, CPGs subject to
adaptive evolution using codon models.
doi:10.1371/journal.pone.0002295.g002
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cruzi components of mammalian serum and cAMP are known to
stimulate differentiation of proliferative epimastigotes to infective
metacyclic trypomastigotes via adenylate cyclases [30,31]. Frai-
denraich et al 1993 showed that adenylate cyclase can bind a-
globin peptide in the insect vector gut following a blood meal.
They postulated that ‘‘T. cruzi could have several receptors with
different specificity for globin derived peptides, or alternatively,
only one receptor specific for a common domain shared by several
a-globin chain species’’ [31]. Our results support the former
hypothesis that positive selection has driven the adaptive evolution
of the extracellular domain whilst functional constraint retains the
intracellular domain by purifying selection.
This proposal is supported by experiments which demonstrate
that in the LBP amide receptor of P. aeruginosa, mutation of Thr-
Asn at position 106 alters ligand specificity, but that this is due to a
change in conformation rather than T106 binding the ligand
directly [32]. However, not all changes may alter function. For
example, it has been shown that adaptive changes in the
homologous AmiC ligand binding protein of P. aeruginosa which
affect ligand specificity result in an unstable protein [33].
Therefore only a subset of mutations may actually alter substrate
binding specificity or dynamics, whilst others may be compensa-
tory to maintain structural stability. The number of positively
selected sites residing in the 2LBP homologous region varies
between clusters from 0 in cluster 21139502 to 17 in cluster
21943524, but in all clusters a greater number of positively
selected sites were detected in the receptor 2LBP like portion
compared to the catalytic 1FX4 domain. When mapped onto the
2LBP sequence, the sites are dispersed between the two lobes of
the clam shell-like structure. Which come into close proximity to
the ligand after binding and closing of the clam shell, (Figure 3b).
Additionally a large number of sites are located in the region of
unpredicted function between the 2LBP homologous region and
the predicted TM domain.
Adaptive Evolution: Implications for Parasite Biology
The impact of adaptive evolution on parasite biology stems
from the premise that the fixation of duplicated genes is an
adaptive event; that these duplicated genes act as a source for
protein subfunctionalisation [12] by evolution of key positions in
the protein, and that this adaptation is reflective of organism-
specific selective pressures.
Importantly, the availability and continued understanding of a
gene and genome evolution allows the rational design of
experiments to assess function of positively evolving or extended
gene families. If a gene of interest is part of a gene family,
experimental procedures may result in little or unexpected results.
For example, gene knockout is a powerful tool, but may not
remove a phenotype if only part of the complement of a gene
family is removed, e.g. McGwire et. al. [34] noted that the
knockout of a single GP63 gene in Leishmania did not completely
attenuate the parasite migration through the extracellular matrix
and where removal of seven GP63 genes was required to reduce
infectivity of L. major [35]. This residual enzymatic action can be
explained by subfunctionalization of the duplicated genes. Thus
experiments should be targeted to identify more subtle effects or
Figure 3. Codon-specific analysis of receptor-type adenylate
cyclase genes. Homologous extracellular codons with predicted v.1
are mapped to the tertiary structure of E. coli leucine-binding protein
(PDB 2LBP [28]) or L-leucine-binding protein with leucine bound (PDB
1USK [56]). Intracellular codons that are predicted to be under positive
selection are mapped to the tertiary structure of T. brucei receptor-type
adenylate cyclise (PDB 1FX2 [25]). A) Hypothetical representation of the
intact Trypanosome adenylate cyclase molecule. The extracellular
region is composed of an N-terminal region homologous to 2LBP and
a region of unknown function. A single transmembrane region links to
the conserved C-terminal catalytic domain. Positively selected sites
(posterior probability $0.95) homologous to crystal structures are
shown as space filled residues. Red, CPG 21943524. Blue, 20115358.
Green, 19651441. Positively selected sites in regions not homologous to
a known crystal structure are shown as coloured circles. B) Position of
positively selected sites following conformation change of extracellular
binding region upon binding to leucine (coloured orange). Orientation
is as for part A.
doi:10.1371/journal.pone.0002295.g003
r
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should incorporate the genomic information such as the knockout
of multiple genes or clusters of duplicated genes.
Adaptive Evolution: Implications for Parasite Control
Selection of a protein as a target for therapeutics or for vaccine
design follows some basic tenets; drug targets should ideally be
pathogen specific genes/pathways so as to avoid affecting the
individual being treated, and vaccine targets should be surface
located to be accessible by the primed host immune system. With
available genome data one can rapidly screen for genes which
encode proteins fitting the above criteria. However, this study
highlights that gene duplication and adaptive evolution should be
considered during screening for potential targets. With regard to
drug therapy, an anti-parasitic drug should be designed differently
depending on whether it is to bind a single protein or to bind all
proteins of a multi-gene family. Thus therapies which target one or
a subset of duplicate genes may not be effective, at low doses due
to binding affinities to variable targets. In this case, it may be more
effective to target a single-copy gene, where removal of function
should offer more complete perturbation of a pathway and hence
more tractable control. Alternatively a drug would need to target a
conserved region of the protein or have large effects at low affinity
when binding to variable members of a protein family.
With respect to parasite vaccine design, it seems logical as
proposed in the context of bacterial and virus vaccine design, that
genes or gene regions undergoing adaptive evolution should be
avoided when considering drug targets [36,37]. This is exemplified
by the long term success of poliovirus vaccines, which has been
related to purifying selection maintaining the sequence and hence
structure of targeted surface proteins [38] conversely targeting the
rapidly evolving proteins of HIV may have contributed to
developing resistance [39]. However, the complexity of this
argument is exemplified in current vaccine candidates for
Plasmodium falciparum control, where the relative merits and
problems of sequence variation in vaccine candidates are currently
discussed [40]. Indeed, both conserved regions [41] and full length
proteins [42] of known polymorphic merozoite surface protein 3
(MSP3) are under investigation as important vaccine candidates,
and it has been reported that polymorphic regions may induce a
stronger immune response [43].
The conflict within these arguments are that potential candidate
genes which are surface expressed and elicit a strong immune
response and hence are good vaccine candidates are also those most
likely to be subject to adaptive evolution. We propose these adaptive
genes may simply be moremalleable by natural selection and thus be
more likely to change in the future, especially under the strong
selective pressure of choreographed therapeutic intervention.
Theoretically therefore the challenge for future design of
vaccines is to identify parasite specific molecules which do not
bear the signature of rapid adaptive change, or to target regions of
proteins distant from rapidly evolving regions. However, the
practicality of design and the biology of the immune response may
require that variable sites in multiple gene families are necessary as
targets. Hence, the availability of complete genome sequence data
is central to this as it allows evolutionary analysis to be
incorporated in vaccine design from inception, stimulating novel
hypotheses relating to the biology of these parasites, and a greater
understanding of pathogen genome evolution.
Materials and Methods
Data collection and manipulation
Predicted protein and cDNA sequences were obtained from the
Sanger Institute ftp server (ftp.sanger.ac.uk/pub/databases/).
Membership of gene families based on reciprocal blastp searches
and single linkage clustering using a jaccard similarity coefficient
was taken from table S1 of El-Sayed et al [8]. Using this approach
8080 T. brucei genes, not labelled as pseudogenes, were grouped
into clusters of orthologous genes (COGs) with T. cruzi and L. major
(6585 3-species and 571 2-species COGs). 924 genes were labelled
as T. brucei specific. Of these 924, 624 were present as single copy
genes and 300 were duplicated in the T. brucei lineage and formed
what we refer to as clusters of paralogous genes (CPGs).
Sequences with less than 10 amino acids were removed and the
remaining aligned using muscle [44]. Protein alignments were
then parsed to remove poorly aligned regions using the Gblocks
algorithm [45] with the following criteria; maximum number of
contiguous non-conserved positions = 10, minimum length of a
block = 5, gap positions allowed in all sequences. These parsed
alignments were then used to construct a corresponding cDNA
alignment. Initial phylogenetic trees were inferred by neighbor
joining under the JC69 model [46].
To predict cellular location, protein products were tested for the
presence of transmembrane (TM) domains using TMHMM
Server v2.0 [47], secretory signal sequences using the Sigcleave
prediction module [48] and glycosylphosphatidylinositol (GPI)
anchor sequences using DGPI (http://129.194.185.165/dgpi/
index_en.html). Sequences were annotated as secreted if they were
secretory signal sequence positive but TM and GPI-anchor
negative, surface expressed if TM or GPI-anchor positive and
intracellular if secretory signal, TM and GPI-anchor negative. All
sequences were compared to a library of Pfam HMMs (obtained
from www.sanger.ac.uk/Software/Pfam/ftp.shtml on 27/06/
2007) using HMMER [49].
Detection of adaptive evolution
A ‘‘gene-wide’’ estimate of adaptive evolution was estimated by
pairwise calculation of dN/dS between all members of a cluster.
Additionally, as adaptive evolution is likely to act on a small subset
of amino acid residues and hence averages of substitution rates
across the gene may not strictly indicate positive selection [4] we
scanned the CPGs with three or more members (40 CPGs, 171
genes) for adaptive evolution using a codon model. To achieve
this, data are fitted to codon-based substitution models that allow
v to vary among sites, with the parameters of the model estimated
using maximum likelihood [4]. The analysis was conducted using
the CodeML application from the PAML package version 3.15
[50]. For each pair of nested models the log likelihood values are
compared using the likelihood ratio test (LRT). If the model
allowing positive selection fits the data significantly better, as
judged by the LRT, positive selection is inferred [51]. In this study
we used two pairs of models: M1 (neutral) versus M2 (selection)
[52]; and M7 (beta) versus M8 (beta+v) [3]. M1 allows two v site
classes with v0,1 estimated from the data or v1 = 1. Whilst M2
allows an additional v2 value to be estimated from the data which
may be .1. M7 fits v to 10 site classes between 0 and 1
approximating a beta distribution and M8 adds an additional site
class with an v possibly .1, estimated from the data. Both M1-
M2 and M7-M8 comparisons were performed with 2 degrees of
freedom. To speed the likelihood iterations M0 was used to
estimate branch lengths based on the topology of the neighbour
joining trees and the estimates of branch lengths were used as
initial values in estimations by other models. To ascertain
convergence of the likelihood iterations multiple runs were
conducted until the difference between two log likelihoods for
each model were less than or equal to 0.01.
When a gene cluster shows a signature of adaptive evolution
according to the LRTs, the empirical Bayes method [52,53] was
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used to identify specific codons which reside within the site class of
v.1. Codons are identified as undergoing adaptive evolution if
both tests are significant and if the posterior probability under
both M2 and M8 models was $0.95.
Additionally, to stringently test for evidence of positive selection
and to remove the potential identification of relaxed purifying
selection, we conducted a comparison of M8 model (where a single
class of sites is allowed with dN/dS.1) to M8a, where dN/dS=1
[54]. The reliance of three M2 vs M3, M7 vs M8 and M8 vs M8a
nested LRTs to infer positive selection also provides some
protection against false positives identified as a result of potential
recombination events [55].
All sequences predicted to be subject to positive selection were
used to search for homologous sequences in the PDB database of
protein structures (http://www.rcsb.org/pdb/ accessed August
2006) using BLAST [18]. Molsoft ICM browser (molsoft.com) was
used for structural manipulations.
Supporting Information
Table S1 Parameter estimates for all positively selected CPGs.
Clusters of orthologous genes and descriptions from El-Sayed et al
[8]. Parameter estimates predicted by PAML models M0, M1,
M2, M7 and M8.
Found at: doi:10.1371/journal.pone.0002295.s001 (0.19 MB
DOC)
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